Differential alternative polyadenylation (APA) was previously reported to be altered in BC tumors [71], and increased expression of polyadenylation components, like cleavage stimulation factor subunit 3 (CSTF3), was detected in TNBC cell lines. The gene discussed is CSTF3; the disease is breast cancer.